Medical Chemistry

Research Frontiers in Immunotherapy and Checkpoint Inhibitor Chemistry

Chemical development of novel PD-1/PD-L1 and CTLA-4 modulators with improved pharmacokinetic properties and reduced immune-related adverse event profiles.

All Medical Chemistry PhD categories